MedTrace Logo

NGAL and Hepcidin Levels in Hemodialysis Patients in Assiut University Hospital

NCT04083664 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 70

Last updated 2019-09-12

No results posted yet for this study

Summary

To assess the pattern of NGAL and Hepicidin in relation to anemia in End Stage Renal Disease Patients on regular hemodialysis in Assiut University Hospital and study the relation between both NGAL and Hepicidin.

Conditions

  • CKD (Chronic Kidney Disease) Stage 5D

Interventions

DIAGNOSTIC_TEST

NGAL and Hepcidin

Both NGAL and hepcidin are elevated inchronic kidney disease,not only through iron metabolism, but both are also associated with inflammationand may be related to anemia

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Walaa Hosny Hosny, Doctrate · Assiut University

  • Alaa Soliman Alaa Soliman, Doctrate · Assiut University

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-09-04
Primary Completion
2020-09-30
Completion
2020-10-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04083664 on ClinicalTrials.gov